Evidence map›Paper›PMID 39766183›Full record

ArticleCancers2024

Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type I.

Ai Sato, Kiyoshi Takagi, Momoka Yoshida, Mio Yamaguchi-Tanaka, Mikoto Sagehashi, Yasuhiro Miki, Minoru Miyashita, Takashi Suzuki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ai SatoDepartment of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.ORCID 0000-0003-0254-4100
Kiyoshi TakagiDepartment of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.ORCID 0000-0002-5200-6514
Momoka YoshidaDepartment of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Mio Yamaguchi-TanakaDepartment of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.ORCID 0000-0002-4276-5445
Mikoto SagehashiDepartment of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Yasuhiro MikiDepartment of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.ORCID 0000-0003-3618-5652
Minoru MiyashitaDepartment of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Takashi SuzukiDepartment of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.ORCID 0000-0003-0195-815X

Funding

JSPS KAKENHI 23K08065, 24K11736 and 23K19493
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerchemoresistancecollagendiscoidin domain receptor 2 (DDR2)immunohistochemistry

Identifiers

PMID39766183
PMCPMC11674238

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.